Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ibuprofen suspension for closure of patent ductus arteriosus in full-term neonates
IRCT138711291700N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by Shiraz University of Medical Sciences. Started Feb 2008; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT138711291700N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138711291700N1.